SavedAdd your journal

Journals / Phoenix Medical Journal / 2026 / Cilt: 8 Sayı: 2

Neonatal Polycythemia: Clinical Features, Management, and Outcomes from a Turkish Single-Center Cohort

Yenidoğan Polisitemisi: Klinik Özellikler, Yönetim ve Sonuçlar – Tek Merkezli Türk Kohortu

Burcu Bozkaya Yücel(SAMSUN ŞEHİR HASTANESİ)0000-0001-8095-2017
Rengin Şiraneci0000-0002-4785-2046
Pages
332–335
Publication Date
2026-07-10
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This cohort supports guideline-based conservative-first management, selective PET, and structured follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To describe risk factors, clinical manifestations, management, and outcomes of neonatal polycythemia in a large Turkish single-center cohort and to integrate these findings with recent literature.
📊
Key Findings & Data:Material and Methods: Retrospective analysis of 99 neonates admitted between May 2006 and December 2007.
💡
Conclusion & Impact:This cohort supports guideline-based conservative-first management, selective PET, and structured follow-up.
🔬Design:Araştırma Makalesi
📍Scope:2006 Verileri
⚙️Variables:yenidoğan polisitemisi · hiperviskozite · parsiyel değişim transfüzyonu

Abstract

Objective: To describe risk factors, clinical manifestations, management, and outcomes of neonatal polycythemia in a large Turkish single-center cohort and to integrate these findings with recent literature. Material and Methods: Retrospective analysis of 99 neonates admitted between May 2006 and December 2007. Results: Small for gestational age (SGA, 24.2%) and large for gestational age (LGA, 15.2%) were major risk factors. Symptoms occurred in 73.7%, most commonly plethora (48.5%), gastrointestinal signs (20.2%), and central nervous system involvement (12.1%). Partial exchange transfusion (PET) was performed in 36.3%. Follow-up showed mild developmental delays (9–25%), without a significant difference between management groups. Conclusion: Neonatal polycythemia remains clinically important with consistent risk factors and manifestations. This cohort supports guideline-based conservative-first management, selective PET, and structured follow-up.

Özet

Amaç: Yenidoğan polisitemisinin risk faktörlerini, klinik bulgularını, tedavi yaklaşımlarını ve sonuçlarını büyük bir Türk tek merkez kohortunda tanımlamak ve güncel literatürle karşılaştırmak. Gereç ve Yöntem: Mayıs 2006 – Aralık 2007 arasında yatırılarak izlenen 99 yenidoğan retrospektif olarak değerlendirildi. Bulgular: En sık risk faktörleri gestasyonel yaşa göre küçük olma (SGA, %24,2) ve gestasyonel yaşa göre büyük olma (LGA, %15,2) idi. Olguların %73,7’si semptomatikti; en sık pletora (%48,5), gastrointestinal bulgular (%20,2) ve santral sinir sistemi bulguları (%12,1) görüldü. Parsiyel değişim transfüzyonu (PET) %36,3 olguda uygulandı. 12–24 aylık takipte hafif gelişimsel gecikmeler izlendi (%9–25); PET ve konservatif yönetim grupları arasında anlamlı fark saptanmadı. Sonuç: Yenidoğan polisitemisi klinik açıdan önemli bir durum olmaya devam etmektedir. Bulgular konservatif yaklaşımın öncelikli olduğunu, PET’in seçilmiş olgularda uygulanması gerektiğini ve düzenli takip ihtiyacını desteklemektedir.

🔖

Cite This Article

Yücel, B. B., Şiraneci, R. (2026). Neonatal Polycythemia: Clinical Features, Management, and Outcomes from a Turkish Single-Center Cohort. Phoenix Medical Journal, Cilt: 8 Sayı: 2, 332–335. https://doi.org/10.38175/phnx.1906561

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Oh W, Lind J. Blood viscosity in newborn infants with polycythemia. Pediatrics. 1966;37(6):1005–1011.
  2. Ramamurthy RS, Brans YW. Neonatal polycythemia: I. Criteria for diagnosis and treatment. Pediatrics. 1981;68(2):168–174.
  3. Mimouni FB, Lubetzky R, Mandel D. Measurement of hematocrit in neonates: capillary versus venous values. J Perinatol. 2017;37(3):243–246. doi:10.1038/jp.2016.223
  4. Christensen RD. Hematologic Problems of the Neonate. 6th ed. Philadelphia: Elsevier; 2021.
  5. Gomella TL, Cunningham MD, Eyal FG. Neonatology: Management, Procedures, On Call Problems, Diseases, and Drugs. 8th ed. New York: McGraw Hill; 2020.
  6. Chaudhari AR, Bhateja S, Agarwal A, Sharma P, Singh R, Gupta N, et al. Clinical profile and outcome of neonatal polycythemia in North India. Int J Contemp Pediatr. 2023;10(2):168–170. doi:10.18203/23493291.ijcp20230101
  7. Martins AS, Carvalho D, Rodrigues T, Silva M, Pereira L, Gomes F, et al. Risk factors and outcomes of neonatal polycythemia: a Portuguese cohort study. Minerva Pediatr. 2024;76(1):64–71. doi:10.23736/S27245276.21.061239
  8. Raguž M, Prce Ž. Neonatal polycythemia: epidemiology and clinical aspects in a tertiary center in Poland. Pediatr Pol. 2024;99(2):99–104. doi:10.5114/polp.2024.145025
  9. Mimouni FB, Merlob P, Dollberg S, Shamir R, Strauss T, Cohen A, et al. Polycythemia and neonatal outcome: a systematic analysis. Clin Perinatol. 2021;48(2):301–316. doi:10.1016/j.clp.2021.02.003
  10. Baenziger O, Duc G, Bucher HU. Changes in cerebral blood flow velocity during partial exchange transfusion in polycythemic newborns. Pediatr Res. 1995;37(5):635–639. doi:10.1203/00006450-199505000-00012
  11. Wiswell TE, Cornish JD, Northam RS. Necrotizing enterocolitis in full term infants. Pediatrics. 1986;78(4):631–634.
  12. Kallimath S, Patil A, Bharathi S, Rao P, Desai K, Kulkarni V, et al. Hemodynamics in neonates with polycythemia before and after partial exchange transfusion. Front Pediatr. 2024;12:11998. doi:10.3389/fped.2024.1199802
  13. Monzani A, Provero P, Agosti M, Bianchi L, Rossi G, Ferrero P, et al. Neonatal polycythemia: incidence, clinical features and management in a prospective cohort. Ital J Pediatr. 2022;48:62. doi:10.1186/s13052-022-01284-4
  14. Arslan H, Demir S, Yücel B, Kaya M, Çelik T, Özkan A, et al. Partial exchange transfusion in neonatal polycythemia: efficacy and complications. Turk Med Stud J. 2023;10(2):75–81. doi:10.4274/tmsj.galenos.2023.202362
  15. Black VD, Lubchenco LO, Koops BL, Poland RL, Hays T, Powell DP, et al. Neonatal hyperviscosity: randomized study of partial plasma exchange transfusion. Pediatrics. 1985;75(6):1048–1053.
  16. Monset Couchard M, de Bethmann O, Relier JP. Long term neurodevelopmental outcome of neonates with polycythemia: a controlled study. J Pediatr. 2018;197:72–78. doi:10.1016/j.jpeds.2018.01.038
  17. Cochrane Neonatal Group. Partial exchange transfusion for neonatal polycythemia. Cochrane Database Syst Rev. 2020;CD005089. doi:10.1002/14651858.CD005089.pub3
  18. UCSF Neonatology Clinical Consensus. Guidelines for the management of neonatal polycythemia. University of California, San Francisco; 2023.
  19. Christensen RD. Neonatal erythrocyte disorders. In: Gleason CA, Juul SE, eds. Avery’s Diseases of the Newborn. 10th ed. Philadelphia: Elsevier; 2018. p.1152–1179.
  20. Goldberg K, Lubchenco LO, Koops BL. Neonatal hyperviscosity: clinical manifestations. J Pediatr. 1982;100(6):999–1004.
  21. Monset Couchard M, Relier JP. Polycythemia in neonates: clinical and developmental outcomes. Biol Neonate. 1984;46(2):61–67.
  22. Pereira S, Martins R, Silva A, Costa J, Almeida P, Fernandes M, et al. Neonatal polycythemia: clinical features and outcomes. Port J Pediatr. 2019;50(3):145–151.
  23. Koc E, Erdem G, Yurdakök M. Neonatal polycythemia: clinical presentation and management. Turk J Pediatr. 2000;42(2):123–128.
  24. Yurdakök M, Koc E, Erdem G. Partial exchange transfusion in neonatal polycythemia. Turk J Pediatr. 2001;43(1):45–50.
  25. Goldberg K, Lubchenco LO, Koops BL. Neonatal polycythemia: risk factors and outcomes. Clin Perinatol. 1985;12(3):489–500.